Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelParallel CC RP 4.3x15mm: medical device reports filed with FDA

4,540 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

4,540
device reports naming the brand
0% of all MAUDE reports · about 665 a year
702
reports, 12 months to August 2026
635 in the 12 months before
1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,540 reports that name the brand "NobelParallel CC RP 4.3x15mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

702 reports arrived in the 12 months to August 2026, up 11% from 635 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99%) and malfunction (1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (67.3%), loss of osseointegration (22.6%) and osseointegration problem (5.9%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

084168Sep 2021: 43Oct 2021: 40Nov 2021: 56Dec 2021: 632022Jan 2022: 46Feb 2022: 39Mar 2022: 48Apr 2022: 39May 2022: 67Jun 2022: 36Jul 2022: 36Aug 2022: 41Sep 2022: 25Oct 2022: 51Nov 2022: 49Dec 2022: 302023Jan 2023: 31Feb 2023: 52Mar 2023: 40Apr 2023: 51May 2023: 69Jun 2023: 49Jul 2023: 31Aug 2023: 32Sep 2023: 38Oct 2023: 35Nov 2023: 52Dec 2023: 372024Jan 2024: 77Feb 2024: 63Mar 2024: 60Apr 2024: 46May 2024: 78Jun 2024: 60Jul 2024: 65Aug 2024: 29Sep 2024: 40Oct 2024: 58Nov 2024: 46Dec 2024: 742025Jan 2025: 66Feb 2025: 52Mar 2025: 58Apr 2025: 4May 2025: 0Jun 2025: 7Jul 2025: 168Aug 2025: 62Sep 2025: 62Oct 2025: 58Nov 2025: 62Dec 2025: 762026Jan 2026: 62Feb 2026: 68Mar 2026: 62Apr 2026: 56May 2026: 60Jun 2026: 44Jul 2026: 50Aug 2026: 42

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03496982019: 32120192020: 69820202021: 68220212022: 50720222023: 51720232024: 69620242025: 67520252026: 4442026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99%4,495
Malfunction1%45
Other0%0
Not given0%0

Who filed the report

Manufacturer report59.3%2,690
Voluntary report0%0
User facility report0%0
Distributor report40.7%1,850
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,05567.3%62.8%
Loss of osseointegration1,02822.6%22.4%
Osseointegration problem2705.9%7.7%
Fracturea broken bone721.6%1.6%
Patient device interaction problem190.4%0.3%
Migrationthe device moved from where it was placed160.4%0.1%
Malposition of device140.3%0.1%
Material deformation100.2%0.1%
Insufficient device problem information90.2%0.2%
Difficult to insertthe device was hard to insert80.2%0.4%
Premature separation40.1%0.1%
Separation failure30.1%0.1%
Activation, positioning or separation problem20%0%
Device damaged by another device20%0%
Device markings/labelling problema problem with the device markings or label10%0%
Inadequacy of device shape and/or size10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant3,57278.7%
Painpain, site not specified63514%
Numbnessnumbness1383%
Appropriate clinical signs, symptoms and conditions term/code not available541.2%
Implant pain220.5%
Inflammationinflammation210.5%
Sinus perforation210.5%
Abscessa collection of pus190.4%
Bone fracture(s)120.3%
Fistula70.2%
Foreign body in patientpart of a device left in the patient40.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelParallel CC RP 4.3x15mmProduct code DZEAll MAUDE reports
Reports4,5403,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury99%99.2%36.2%
Classified as malfunction1%0.8%62.3%
Filed by the manufacturer59.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelParallel CC RP 4.3x15mm reports

How many FDA reports name NobelParallel CC RP 4.3x15mm?

4,540 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 702 in the latest 12 months.

What kinds of events are reported?

injury (99%) and malfunction (1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (67.3%), loss of osseointegration (22.6%), osseointegration problem (5.9%), fracture (1.6%) and patient device interaction problem (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (59.3%) and distributor reports (40.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelParallel CC RP 4.3x15mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.